Enterogermina
- Secure and encrypted payment processing
- We ship to over 40 countries including the USA, UK, Europe, Australia and Japan
- Guaranteed refund or reship if you haven't received your order
Enterojermina® FORTE is a probiotic containing spores of the multiresistant strain of Bacillus clausii, an antidiarrheal preparation for the restoration of intestinal microflora.
Act
Bacillus clausii spores, which are present in the preparation, are usually present in the intestine and do not exhibit pathogenic activity. Due to the action of Bacillus clausii, the drug restores the intestinal microflora, which is suppressed as a result of treatment with drugs that lead to dysbiosis. In addition, due to the ability of Bacillus clausii to synthesize various vitamins, especially group B, the drug contributes to the correction of disvitaminosis caused by the use of antibiotics or chemotherapeutic drugs. It can be used during pregnancy and lactation.
Benefits
Probiotics in the human body perform several functions:
- Inhibition of pathogenic microflora;
- Restore normal microflora;
- The synthesis of vitamins, mainly group B.
The antimicrobial effect of probiotics containing Bacillus clausii in their composition begins after 2 hours.
The use of a probiotic reduces the following side effects from the 1st day of taking the antibiotic: abdominal pain;
Probiotic has immunomodulatory activity.
The bacteria of the strain Bacillus clausii contained in probiotics are among the most studied probiotic microorganisms.
They are:
- Resistant to gastric juice, bile acids, antibacterial drugs.
- They have a studied mechanism of action and a proven high safety profile.
Microorganisms of the strain Bacillus clausii are recommended by the World Gastroenterological Organization and are approved for use during pregnancy and lactation.
Indications for use
Treatment and prevention of intestinal dysbiosis and associated endogenous disvitaminosis.
Ancillary therapy aimed at restoring normal intestinal microflora, which is disturbed during treatment with antibiotics or chemotherapeutic drugs.
Acute and chronic gastrointestinal diseases in infants associated with intoxication or intestinal dysbiosis and dysvitaminosis.
Contraindications
Hypersensitivity to the active substance or to any of the excipients.
Dosage and administration
Adults 5 ml (1 bottle) per day.
Children: the drug is used in infants and children in a dose of 5 ml (1 bottle) per day.
The contents of the vial are taken without dilution or diluted in water or other drinks (for example, milk, tea or orange juice).
This medicine is intended for oral use only.
Do not administer parenterally or use in any other way.
The term of treatment is determined by the doctor depending on the patients condition and the course of the disease.
Treatment and prevention of intestinal dysbiosis and associated endogenous disvitaminosis - 5-7 days.
Auxiliary therapy aimed at restoring normal intestinal microflora, which is disturbed during treatment with antibiotics or chemotherapeutic drugs - during antibiotic therapy (on average 5-10 days).
Acute and chronic gastrointestinal diseases in infants associated with intoxication or intestinal dysbiosis and dysvitaminosis: acute - 5-7 days, chronic - up to 30 days.
Children
The drug can be used for children aged 28 days.
Use during pregnancy or lactation
There are no contraindications to the use of the drug during pregnancy and lactation.
Structure
Active ingredient: spores of a multiresistant strain of Bacillus clausii; 1 vial of 5 ml contains spores of the multiresistant strain of Bacillus clausii - 4x10 9 .
Excipients: purified water.
Storage conditions
Keep out of reach of children at temperatures below 30 ° C.
To avoid contamination of the suspension, do not open the vial in advance.